Loading...

Ronald T Mitsuyasu

Title(s)Professor-in-Residence, Medicine
SchoolMedicine
Address760 Westwood Plaza 32-144
Los Angeles CA 90024
Phone310-825-3807
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
    NIH/NCI R21CA177310Aug 1, 2013 - Jul 31, 2015
    Role: Principal Investigator
    South American Program in HIV Prevention Research (SAPHIR)
    NIH/NIMH R25MH087222Aug 1, 2011 - May 31, 2021
    Role: Co-Principal Investigator
    AIDS Malignancy Clinical Trials Consortium (AMC)
    NIH/NCI U01CA121947Aug 29, 2006 - Jul 31, 2010
    Role: Principal Investigator
    AIDS Malignancy Consortium (AMC)
    NIH/NCI UM1CA121947Mar 1, 2006 - Aug 31, 2020
    Role: Principal Investigator
    AIDS-ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM
    NIH/NCI U01CA070080Aug 1, 1999 - Mar 31, 2007
    Role: Principal Investigator
    AIDS INSTITUTIONAL TRAINING GRANT
    NIH/NIAID T32AI007388Aug 1, 1990 - Jun 30, 2001
    Role: Co-Principal Investigator
    AIDS CLINICAL TRIALS UNIT
    NIH/NIAID U01AI027660Jun 30, 1986 - Jun 30, 1991
    Role: Co-Principal Investigator
    PHYSICIAN-INVESTIGATOR DEVELOPMENT AWARD PROGRAM
    NIH/NCI K08CA000932Jun 1, 1984 - Apr 30, 1987
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Randomized Clinical Trial of Infrared Coagulation Ablation Versus Active Monitoring of Intra-anal High-grade Dysplasia in Adults With Human Immunodeficiency Virus Infection: An AIDS Malignancy Consortium Trial. Clin Infect Dis. 2019 03 19; 68(7):1204-1212. Goldstone SE, Lensing SY, Stier EA, Darragh T, Lee JY, van Zante A, Jay N, Berry-Lawhorn JM, Cranston RD, Mitsuyasu R, Aboulafia D, Palefsky JM, Wilkin T. PMID: 30060087.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    2. Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption. PLoS One. 2019; 14(1):e0210965. Rockstroh JK, Asmuth D, Pantaleo G, Clotet B, Podzamczer D, van Lunzen J, Arastéh K, Mitsuyasu R, Peters B, Silvia N, Jolliffe D, Ökvist M, Krogsgaard K, Sommerfelt MA. PMID: 30699178.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    3. Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas. Blood Adv. 2018 12 26; 2(24):3618-3626. Reid EG, Looney D, Maldarelli F, Noy A, Henry D, Aboulafia D, Ramos JC, Sparano J, Ambinder RF, Lee J, Cesarman E, Yahyaei S, Mitsuyasu R, Wachsman W. PMID: 30573564.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    4. The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis. 2018 11 05; 218(12):1954-1963. Namazi G, Fajnzylber JM, Aga E, Bosch RJ, Acosta EP, Sharaf R, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest D, Margolis D, Sneller MC, Little SJ, Gianella S, Smith DM, Kuritzkes DR, Gulick RM, Mellors JW, Mehraj V, Gandhi RT, Mitsuyasu R, Schooley RT, Henry K, Tebas P, Deeks SG, Chun TW, Collier AC, Routy JP, Hecht FM, Walker BD, Li JZ. PMID: 30085241.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    5. HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J Clin Invest. 2018 08 31; 128(9):4074-4085. Sharaf R, Lee GQ, Sun X, Etemad B, Aboukhater LM, Hu Z, Brumme ZL, Aga E, Bosch RJ, Wen Y, Namazi G, Gao C, Acosta EP, Gandhi RT, Jacobson JM, Skiest D, Margolis DM, Mitsuyasu R, Volberding P, Connick E, Kuritzkes DR, Lederman MM, Yu XG, Lichterfeld M, Li JZ. PMID: 30024859.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    6. Clinical and scientific challenges in HIV-associated malignancies. Curr Opin HIV AIDS. 2017 01; 12(1):1-5. Polizzotto MN, Mitsuyasu RT. PMID: 27763914.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial. J Clin Oncol. 2017 Mar; 35(7):727-733. Sparano JA, Lee JY, Palefsky J, Henry DH, Wachsman W, Rajdev L, Aboulafia D, Ratner L, Fitzgerald TJ, Kachnic L, Mitsuyasu R. PMID: 27937092.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    8. Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy. J Cancer Epidemiol. 2016; 2016:2138259. Lee JY, Dhakal I, Casper C, Noy A, Palefsky JM, Haigentz M, Krown SE, Ambinder RF, Mitsuyasu RT. PMID: 27882054.
      View in: PubMed   Mentions:
    9. HIV and cancer registry linkage identifies a substantial burden of cancers in persons with HIV in India. Medicine (Baltimore). 2016 Sep; 95(37):e4850. Godbole SV, Nandy K, Gauniyal M, Nalawade P, Sane S, Koyande S, Toyama J, Hegde A, Virgo P, Bhatia K, Paranjape RS, Risbud AR, Mbulaiteye SM, Mitsuyasu RT. PMID: 27631245.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leuk Lymphoma. 2016 07; 57(7):1731-4. Noy A, Lensing SY, Moore PC, Gupta N, Aboulafia D, Ambinder R, Baiocchi R, Dezube BJ, Henry D, Kaplan L, Levine AM, Mitsuyasu R, Ratner L, Reid E, Remick S, Sparano J, Tzachanis D, Wachsman W, Chadburn A. PMID: 26674561.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial). Clin Cancer Res. 2016 Jan 15; 22(2):328-36. Epeldegui M, Lee JY, Martínez AC, Widney DP, Magpantay LI, Regidor D, Mitsuyasu R, Sparano JA, Ambinder RF, Martínez-Maza O. PMID: 26384320.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    12. Non-AIDS-defining cancers. Top Antivir Med. 2014 Jun-Jul; 22(3):660-5. Mitsuyasu RT. PMID: 25101532.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    13. Impact of chemotherapy for HIV-1 related lymphoma on residual viremia and cellular HIV-1 DNA in patients on suppressive antiretroviral therapy. PLoS One. 2014; 9(3):e92118. Cillo AR, Krishnan S, McMahon DK, Mitsuyasu RT, Para MF, Mellors JW. PMID: 24638072.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    14. Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2014 Apr; 14(4):291-300. Pollard RB, Rockstroh JK, Pantaleo G, Asmuth DM, Peters B, Lazzarin A, Garcia F, Ellefsen K, Podzamczer D, van Lunzen J, Arastéh K, Schürmann D, Clotet B, Hardy WD, Mitsuyasu R, Moyle G, Plettenberg A, Fisher M, Fätkenheuer G, Fischl M, Taiwo B, Baksaas I, Jolliffe D, Persson S, Jelmert O, Hovden AO, Sommerfelt MA, Wendel-Hansen V, Sørensen B. PMID: 24525316.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCellsCTClinical Trials
    15. A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061. Cancer. 2014 Apr 15; 120(8):1194-202. Rudek MA, Moore PC, Mitsuyasu RT, Dezube BJ, Aboulafia D, Gerecitano J, Sullivan R, Cianfrocca ME, Henry DH, Ratner L, Haigentz M, Dowlati A, Little RF, Ivy SP, Deeken JF. PMID: 24474568.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    16. Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphoma. J Acquir Immune Defic Syndr. 2013 Aug 01; 63(4):438-41. Cillo AR, Krishnan A, Mitsuyasu RT, McMahon DK, Li S, Rossi JJ, Zaia JA, Mellors JW. PMID: 23493152.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    17. Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection. AIDS. 2013 Jul 17; 27(11):1735-42. Unemori P, Leslie KS, Hunt PW, Sinclair E, Epling L, Mitsuyasu R, Effros RB, Dock J, Dollard SG, Deeks SG, Martin JN, Maurer TA. PMID: 23435301.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    18. Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers. AIDS. 2013 Jun 01; 27(9):1433-41. Borges ÁH, Silverberg MJ, Wentworth D, Grulich AE, Fätkenheuer G, Mitsuyasu R, Tambussi G, Sabin CA, Neaton JD, Lundgren JD. PMID: 23945504.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    19. Curing HIV: lessons from cancer therapy. Curr Opin HIV AIDS. 2013 May; 8(3):224-9. Mitsuyasu R. PMID: 23454863.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. Efavirenz induces autophagy and aberrant differentiation in normal human keratinocytes. Int J Mol Med. 2013 Jun; 31(6):1305-12. Dong Q, Oh JE, Yi JK, Kim RH, Shin KH, Mitsuyasu R, Park NH, Kang MK. PMID: 23563240.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    21. High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccine. HIV Clin Trials. 2013 Mar-Apr; 14(2):75-9. Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry MJ, Jay N, Aboulafia DM, Einstein MH, Saah A, Mitsuyasu RT, Palefsky JM. PMID: 23611828.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    22. Didanosine-associated retinal toxicity in adults infected with human immunodeficiency virus. JAMA Ophthalmol. 2013 Feb; 131(2):255-9. Gabrielian A, MacCumber MM, Kukuyev A, Mitsuyasu R, Holland GN, Sarraf D. PMID: 23411900.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol. 2013 Jan 01; 31(1):58-64. Levine AM, Noy A, Lee JY, Tam W, Ramos JC, Henry DH, Parekh S, Reid EG, Mitsuyasu R, Cooley T, Dezube BJ, Ratner L, Cesarman E, Tulpule A. PMID: 23169503.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    24. Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment. BMC Infect Dis. 2012 Jul 31; 12:168. Sinha S, Shekhar RC, Singh G, Shah N, Ahmad H, Kumar N, Sharma SK, Samantaray JC, Ranjan S, Ekka M, Sreenivas V, Mitsuyasu RT. PMID: 22846195.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    25. The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV-TB co-infected Indian patients receiving rifampicin based antituberculosis treatment. AIDS Res Ther. 2011 Nov 02; 8(1):41. Sinha S, Dhooria S, Kumar S, Shah N, Velpandian T, Ravi A, Kumar N, Ahmad H, Bhargwa A, Chug K, Bumma N, Chandrashekhar R, Ekka M, Sreenivas V, Sharma SK, Samantaray J, Mitsuyasu R. PMID: 22047185.
      View in: PubMed   Mentions: 2     Fields:    
    26. HIV-associated multicentric Castleman disease. Curr Opin Oncol. 2011 Sep; 23(5):475-81. Reddy D, Mitsuyasu R. PMID: 21760504.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    27. Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt. Stem Cells Int. 2011; 2011:393698. Mitsuyasu RT, Zack JA, Macpherson JL, Symonds GP. PMID: 21716651.
      View in: PubMed   Mentions:
    28. Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals. J Clin Immunol. 2011 Oct; 31(5):873-81. Hoffman RM, Jamieson BD, Bosch RJ, Currier J, Kitchen CM, Schmid I, Zhu Y, Bennett K, Mitsuyasu R. PMID: 21643890.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    29. Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis. Oncology. 2011; 80(1-2):42-9. Krishnan S, Schouten JT, Jacobson DL, Benson CA, Collier AC, Koletar SL, Santana J, Sattler FR, Mitsuyasu R. PMID: 21606663.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    30. A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment. J Interferon Cytokine Res. 2011 Jun; 31(6):481-3. Bosch RJ, Pollard RB, Landay A, Aga E, Fox L, Mitsuyasu R. PMID: 21291323.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    31. Pilot assessment of HIV gene therapy-hematopoietic stem cell clinical trial acceptability among minority patients and their advisors. J Natl Med Assoc. 2010 Dec; 102(12):1123-8. King WD, Wyatt GE, Liu H, Williams JK, DiNardo AD, Mitsuyasu RT. PMID: 21287892.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    32. Cancer biomarkers in HIV patients. Curr Opin HIV AIDS. 2010 Nov; 5(6):531-7. Ambinder RF, Bhatia K, Martinez-Maza O, Mitsuyasu R. PMID: 20978397.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    33. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men. J Infect Dis. 2010 Oct 15; 202(8):1246-53. Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry JM, Jay N, Aboulafia D, Cohn DL, Einstein MH, Saah A, Mitsuyasu RT, Palefsky JM. PMID: 20812850.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCellsCTClinical Trials
    34. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS. 2009 Mar 13; 23(5):605-10. Stapleton JT, Chaloner K, Zhang J, Klinzman D, Souza IE, Xiang J, Landay A, Fahey J, Pollard R, Mitsuyasu R. PMID: 19194270.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    35. Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells. Nat Med. 2009 Mar; 15(3):285-92. Mitsuyasu RT, Merigan TC, Carr A, Zack JA, Winters MA, Workman C, Bloch M, Lalezari J, Becker S, Thornton L, Akil B, Khanlou H, Finlayson R, McFarlane R, Smith DE, Garsia R, Ma D, Law M, Murray JM, von Kalle C, Ely JA, Patino SM, Knop AE, Wong P, Todd AV, Haughton M, Fuery C, Macpherson JL, Symonds GP, Evans LA, Pond SM, Cooper DA. PMID: 19219022.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansCellsCTClinical Trials
    36. Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J Immunol. 2008 Nov 15; 181(10):7400-6. Fauce SR, Jamieson BD, Chin AC, Mitsuyasu RT, Parish ST, Ng HL, Kitchen CM, Yang OO, Harley CB, Effros RB. PMID: 18981163.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    37. Non--AIDS-defining malignancies in HIV. Top HIV Med. 2008 Oct-Nov; 16(4):117-21. Mitsuyasu RT. PMID: 18838745.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    38. Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy. J Interferon Cytokine Res. 2008 Feb; 28(2):89-100. Davey RT, Pertel PE, Benson A, Cassell DJ, Gazzard BG, Holodniy M, Lalezari JP, Levy Y, Mitsuyasu RT, Palella FJ, Pollard RB, Rajagopalan P, Saag MS, Salata RA, Sha BE, Choudhri S. PMID: 18279104.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    39. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328. Arch Intern Med. 2007 Mar 26; 167(6):597-605. Mitsuyasu R, Gelman R, Cherng DW, Landay A, Fahey J, Reichman R, Erice A, Bucy RP, Kilby JM, Lederman MM, Hamilton CD, Lertora J, White BL, Tebas P, Duliege AM, Pollard RB. PMID: 17389292.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    40. A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024). J Infect Dis. 2006 Dec 15; 194(12):1672-6. Kilby JM, Bucy RP, Mildvan D, Fischl M, Santana-Bagur J, Lennox J, Pilcher C, Zolopa A, Lawrence J, Pollard RB, Habib RE, Sahner D, Fox L, Aga E, Bosch RJ, Mitsuyasu R. PMID: 17109338.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    41. Quality of life in a clinical trial of highly active antiretroviral therapy alone or with intravenous or subcutaneous interleukin-2 administration. J Acquir Immune Defic Syndr. 2005 Dec 01; 40(4):428-33. Martin BK, Wu AW, Gelman R, Mitsuyasu RT. PMID: 16280697.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    42. Differential effect of interleukin-2 treatment on primary and secondary immunizations in HIV infected individuals. AIDS. 2005 Nov 18; 19(17):1967-74. Kuekrek H, Schlingmann T, Valdez H, Boehm BO, Pollard RB, Mitsuyasu R, Goebel FD, Lederman MM, Lehmann PV, Tary-Lehmann M. PMID: 16260902.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic Health
    43. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004 May 15; 38(10):1454-63. Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M. PMID: 15156485.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    44. Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum Gene Ther. 2004 Mar; 15(3):251-62. Amado RG, Mitsuyasu RT, Rosenblatt JD, Ngok FK, Bakker A, Cole S, Chorn N, Lin LS, Bristol G, Boyd MP, MacPherson JL, Fanning GC, Todd AV, Ely JA, Zack JA, Symonds GP. PMID: 15018734.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCellsCTClinical Trials
    45. Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDS. Methods Mol Biol. 2004; 252:581-98. Ngok FK, Mitsuyasu RT, Macpherson JL, Boyd MP, Symonds GP, Amado RG. PMID: 15017082.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    46. A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300 CD4+ T cells. Clin Immunol. 2003 Mar; 106(3):188-96. de Boer AW, Markowitz N, Lane HC, Saravolatz LD, Koletar SL, Donabedian H, Yoshizawa C, Duliege AM, Fyfe G, Mitsuyasu RT. PMID: 12706405.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    47. Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s. J Infect Dis. 2003 Jan 15; 187(2):320-5. Valdez H, Mitsuyasu R, Landay A, Sevin AD, Chan ES, Spritzler J, Kalams SA, Pollard RB, Fahey J, Fox L, Namkung A, Estep S, Moss R, Sahner D, Lederman MM. PMID: 12552459.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    48. Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects. AIDS. 2003 Jan 03; 17(1):53-63. Anton PA, Mitsuyasu RT, Deeks SG, Scadden DT, Wagner B, Huang C, Macken C, Richman DD, Christopherson C, Borellini F, Lazar R, Hege KM. PMID: 12478069.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    49. Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial. JAMA. 2002 Jul 10; 288(2):169-80. Hammer SM, Vaida F, Bennett KK, Holohan MK, Sheiner L, Eron JJ, Wheat LJ, Mitsuyasu RT, Gulick RM, Valentine FT, Aberg JA, Rogers MD, Karol CN, Saah AJ, Lewis RH, Bessen LJ, Brosgart C, DeGruttola V, Mellors JW. PMID: 12095381.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    50. Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2. AIDS Res Hum Retroviruses. 2002 Jun 10; 18(9):661-5. Sha BE, Valdez H, Gelman RS, Landay AL, Agosti J, Mitsuyasu R, Pollard RB, Mildvan D, Namkung A, Ogata-Arakaki DM, Fox L, Estep S, Erice A, Kilgo P, Walker RE, Bancroft L, Lederman MM. PMID: 12079562.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    51. A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy. Mol Ther. 2002 Jun; 5(6):788-97. Deeks SG, Wagner B, Anton PA, Mitsuyasu RT, Scadden DT, Huang C, Macken C, Richman DD, Christopherson C, June CH, Lazar R, Broad DF, Jalali S, Hege KM. PMID: 12027564.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCellsCTClinical Trials
    52. Immune therapy: non-highly active antiretroviral therapy management of human immunodeficiency virus-infected patients. J Infect Dis. 2002 May 15; 185 Suppl 2:S115-22. Mitsuyasu R. PMID: 12001032.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    53. Immune Reconstitution Strategies in HIV. Curr Infect Dis Rep. 2001 Jun; 3(3):302-308. Leibowitz MR, Mitsuyasu RT. PMID: 11384562.
      View in: PubMed   Mentions:
    54. The potential role of interleukin-2 in HIV. AIDS. 2001 Feb; 15 Suppl 2:S22-7. Mitsuyasu RT. PMID: 11424973.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    55. Prevention of bacterial infections in patients with advanced HIV infection. AIDS. 1999; 13 Suppl 2:S19-23. Mitsuyasu R. PMID: 10596677.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    Ronald's Networks
    Concepts (261)
    Derived automatically from this person's publications.
    _
    Co-Authors (29)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _